'It is a balanced and prudent Budget that sets the foundation for future growth in the economy.'
Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.
As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.
Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.
Presenting Ranveer and the other stylish men who descended on the GQ red carpet!
He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".
What is foreign policy worth if it stands disconnected from domestic realities? Make no mistake, the horrifying visuals of the human suffering in metropolitan India is only the tip of the iceberg. The vast swathes of the hinterland are heaving with untold sorrows, notes Ambassador M K Bhadrakumar.
Karan Johar hosted a huge birthday party for Apoorva Mehta, the CEO of Dharma Productions, who turned 50 on March 17.
The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Malaika Arora invited her friends to celebrate her 46th birthday, and what a turnout it was!
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
Pune-based entrepreneur's unlisted company is already the largest vaccine manufacturer in the world and the networth has been helped by vaccine distribution and manufacturing potential of his business, it added. Recentrly, Serum struck an agreement with AstraZeneca to manufacture 1 billion doses of coronavirus vaccine being developed by Oxford University.
'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'
Learn how to host parties from the Ambanis!
As India launched the world's largest vaccination drive against the coronavirus pandemic, showing the light at the end of a 10-month tunnel that upended millions of lives and livelihoods, here are some of the quotes from politicians across parties and other people who took the jab:
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.
'We are hoping by March, the government allows us to export and give it to the private market.'
The Indian State has low operational capabilities. Individuals will have concerns about material that flows through the government, on questions of purity, perfection of the cold chain, and correctness of procedures at the frontline. Even if a government programme is able to solve all these problems, it will be limited in scale-up. The passion, management capabilities, and response to local conditions, which will be found with tens of thousands of ground-level initiatives, Individuals will have concerns about material that flows through the government, on questions of purity, perfection of the cold chain, and correctness of procedures. Even if a government programme is able to solve all these problems, it will be limited in scale-up, argues Ajay Shah.
Both manufacturers have sought funds in excess of Rs 150 crore under the department of biotechnology's Mission Covid Suraksha scheme. Announced last November, the scheme has an outlay of Rs 900 crore to help develop Covid vaccines, from the clinical development stage to setting up production sites.
'Parsis are brought up with a great sense of the importance of truth and speaking your mind.'
A dipstick survey covering 30 villages in Rajasthan threw up some worrisome numbers. About 250 children missed their regular vaccination schedule in March alone. These numbers are alarming, since India has around 600,000 villages according to the 2011 census. Sohini Das reports.
The development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union health ministry that the firm would be able to supply 20.29 crore doses of Covishied in the month of September.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
'There is a Covid vaccine-mania that is happening in the world now and the vaccine makers are using this mania for their own gains'
Loud applause and cheers rang out as the first jabs were administered to frontline workers at hospitals and healthcare centres across the country on Saturday at the start of the gargantuan COVID-19 vaccination exercise, hailed as a 'momentous' occasion in India's fight against the pandemic.
'I think Ratan felt he had to do everything that he could to retain control of the company started by his forefathers, because that was the first priority and nothing else mattered compared to that.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances